Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

InfuSystem Holdings (INFU) EBITDA (2016 - 2025)

InfuSystem Holdings' EBITDA history spans 16 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 61.1% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $6.1 million, up 155.6%, while the annual FY2025 figure was $6.1 million, 155.6% up from the prior year.
  • EBITDA reached $2.0 million in Q4 2025 per INFU's latest filing, down from $2.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $2.4 million in Q2 2025 to a low of -$904000.0 in Q1 2024.
  • Average EBITDA over 5 years is $592350.0, with a median of $654000.0 recorded in 2021.
  • The largest YoY upside for EBITDA was 2790.48% in 2023 against a maximum downside of 15700.0% in 2023.
  • A 5-year view of EBITDA shows it stood at $585000.0 in 2021, then tumbled by 100.51% to -$3000.0 in 2022, then tumbled by 15700.0% to -$474000.0 in 2023, then skyrocketed by 356.54% to $1.2 million in 2024, then surged by 61.1% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for INFU's EBITDA are $2.0 million (Q4 2025), $2.2 million (Q3 2025), and $2.4 million (Q2 2025).